<DOC>
	<DOCNO>NCT00886366</DOCNO>
	<brief_summary>The purpose study assess safety tolerability AZD6714 single ascend oral dos healthy male subject type 2 diabetic patient .</brief_summary>
	<brief_title>Single Ascending Dose Study With Healthy Male Volunteers Type II Diabetic Patients</brief_title>
	<detailed_description />
	<criteria>Part A , Healthy male subject , age ≥20 ≤40 year . Part B , Male T2DM patient , age ≥20 ≤65 year . Treatment metformin single therapy T2DM least 30 day prior enrollment Part A , Clin sign illness clin relevant trauma , judge investigator , within 2 week first administration IP . Part A Clin sign abnormality clinical chemistry , haematology , urinalysis result judge investigator Part B , History ischemic heart disease , symptomatic heart failure , stroke , transitory ischemic attack symptomatic peripheral vascular disease . Any clinically significant abnormality identify physical examination , laboratory test ECG , judgment investigator would compromise patient 's safety successful participation .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Type II Diabetes</keyword>
</DOC>